Date of Award
5-2023
Degree Type
Thesis
Degree Name
Master of Science (MS)
Department
Chemistry
First Advisor
Benjamin J. Alper, Ph.D.
Abstract
Expre ed in nearly all mammalian tissues, insulin-degrading enzyme (IDE) is a ubiquitous zinc endopeptida e which cleaves many peptides endogenous to human and other organisms. IDE is implicated to hold vital roles in homeostasis, involved in several cellular pathways related to cellular growth, proteasome turnover, and heat- hock respon e. The enzyme also hydrolyzes several ligands of medical interest, such as insulin, amyl in, and amyloid-beta peptide in vivo, and calcitonin, ghrelin, glucagon, and atrial natriuretic peptide in vitro. However, while much is known about the enzyme's function, the mechanism of the IDE cleavage reaction remains poorly understood. The tudy of enzyme inhibition is a vital tool for understanding enzymatic mechanisms of action, and for drug design overall. Here, several new inhibitor of IDE are characterized. These inhibitors belong to a family of broad-spectrum antibiotic commonly used in the field of medicine.
Recommended Citation
Sarno, Jake, "New Inhibitors of Insulin-Degrading Enzyme" (2023). Chemistry Master’s Theses. 60.
https://digitalcommons.sacredheart.edu/chem_thes/60
Comments
Master's thesis submitted to the Faculty of the Department of Chemistry at Sacred Heart University in partial fulfillment of the requirements for the degree of Master of Science.